Search results
CureVac N.V. (NASDAQ:CVAC) Q3 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoCureVac N.V. (NASDAQ:CVAC) Q3 2022 Earnings Call Transcript November 16, 2022 CureVac N.V. beats...
Dow Jones Soars 477 Points As Nvidia Falls; Donald Trump Stock Surges 14%
Investor's Business Daily· 3 months agoMajor indexes rallied in the last hour of trading Wednesday as the Dow Jones Industrial Average and...
Innovators celebrated, inventions showcased at event by UF Innovate's Tech Licensing
The Gainesville Sun via Yahoo News· 8 months agoTables with up-and-coming inventions that include an environment-scanning robot and augmented...
Gulf Resources, Inc. (NASDAQ:GURE) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoGulf Resources, Inc. (NASDAQ:GURE) Q3 2023 Earnings Call Transcript November 21, 2023 Operator:...
15 Countries with the Highest Prostate Cancer Rates in the World
Insider Monkey via Yahoo Finance· 3 months agoIn this article, we will be taking a look at the 15 countries with the highest prostate cancer rates...
Q3 2023 CureVac NV Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 months agoParticipants Alexander Zehnder; CEO, MD & Member of Management Board; CureVac N.V. Marcus Dalton Myriam Mendila; Chief Development Officer, MD & Member of the Management Board; CureVac N.V.
This New Drug May Be Our Best Chance in Fighting Alzheimer’s
The Daily Beast via Yahoo News· 11 months agoAndrew BrookesA new Alzheimer’s drug has been shown to significantly slow the disease’s progression...
Arbutus (ABUS) to Focus on Hepatitis B Candidates, Stock Up
Zacks via Yahoo Finance· 9 months agoArbutus (ABUS) makes a strategic decision to focus on the development of hepatitis B virus therapies...
Institute scientists publish research that could lead to melanoma vaccine
Austin Daily Herald, Minn. via Yahoo News· 1 year agoMar. 2—A team of scientists at The Hormel Institute, University of Minnesota, led by George Aslanidi, PhD, Professor and leader of the Molecular Bioengineering and Cancer Vaccine research section ...